Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
775.00 | -49.06% | -28.16% | 697,814.17 | 0.67% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
148.95 | 0% | 0% | 358,474.86 | 3.34% | 2.71% |
|
NYSE:MRK
Merck
|
129.55 | -8.88% | 4.48% | 328,125.06 | 2.36% | -19.03% |
|
NYSE:PFE
Pfizer
|
28.27 | 9.82% | 40.42% | 160,080.04 | 6.05% | -9.31% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
955.76 | -27.64% | -21.47% | 105,310.9 | 0% | 13.9% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
418.82 | 4.06% | 12.3% | 108,077.92 | 0% | 30.14% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.67 | 63.07% | 73.49% | 88,523.46 | 5.45% | 13.54% |
|
NYSE:ZTS
Zoetis
|
164.92 | 34.15% | 50.76% | 75,252.19 | 1.03% | 11.19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
152.29 | 0% | 0% | 19,263.43 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.75 | 80.22% | 107.41% | 18,217.49 | 3.21% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.81 | -0.12% | 9.88% | 14,025.19 | 4.1% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
261.09 | -9.01% | 0.54% | 11,583.65 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
56.20 | -57.56% | -7.41% | 10,170.75 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
65.27 | 0% | 0% | 6,838.6 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
40.16 | -,155.7% | -,148.39% | 5,857.17 | 0% | 0% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
208.04 | 0% | 0% | 4,433.65 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
153.28 | -0.56% | 9% | 4,561.9 | 0.51% | 5.85% |
|
NYSE:PRGO
Perrigo Co PLC
|
31.11 | 51.28% | 76.84% | 4,085.81 | 3.66% | -10.73% |
|
NasdaqGS:NEOG
Neogen
|
12.05 | 135.45% | 235.73% | 2,670.77 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
25.40 | -34.78% | -10.92% | 2,552.83 | 0% | 2.03% |
